搜索医生

Anand Srinivasan, M.B.B.S.

  1. Pediatric Hematologist / Oncologist
预约门诊

科室

专业团队

地点

  1. Rochester, Minnesota

语言

EnglishTamilHindi

现有患者

Dr. Anand Srinivasan is a board-certified pediatric hematologist-oncologist with a specialization in hematopoietic stem cell transplantation and cellular therapy. He provides advanced care for children, teens and young adults with blood disorders and cancer.

His clinical interest includes:

  • Allogeneic hematopoietic stem cell transplantation
  • Cellular therapy
  • Haploidentical transplantation using post-transplant cyclophosphamide
  • Graft-versus-host disease

In addition to his clinical interests, Dr. Srinivasan has a strong interest in medical education and provides mentorship to medical students, residents, and fellows.

  1. Acute leukemia
  2. Aplastic anemia
  3. Bone marrow failure syndromes
  4. Immune deficiencies
  1. Bone marrow transplant
  2. Cellular therapy
  • Pediatric hematopoietic stem cell transplantation
  • Haploidentical stem cell transplantation
  • Cellular therapy
  • Bone marrow failure syndromes
  1. 2021
    Fellow - Pediatric Transplant/Cellular TherapyUniversity of Toronto, The Hospitals for Sick Children
  2. 2020
    Fellow - Pediatric Hematology OncologyUniversity of Oklahoma Health Sciences Center
  3. 2017
    Resident - PediatricsColumbia University/The Affiliation at Harlem Hospital
  4. 2013
    BS and MSAmrita School of Medicine

Certifications

  1. 2021
    Pediatric Hematology-OncologyAmerican Board of Pediatrics
  2. 2017
    PediatricsAmerican Board of Pediatrics

Awards and honors

  1. 2023
    Translating Practice into Research (TPIR) Trainee ProgramOklahoma Shared Clinical and Translational Resources
  2. 2022
    Medical Educators Institute awardAmerican Society of Hematology
  3. 2020
    Student research travel awardStephenson Cancer Center
  4. 2019
    ASTCT Travel grant awardAmerican Society of Transplantation and Cellular Therapy
  5. 2019
    Oral presentation award, Pediatric research day “Mouse models of graft versus host disease: Path to testing new therapeutics”University of Oklahoma Health Sciences Center

Professional memberships

  1. 2022 - 2024
    Commiittee MemberPediatric Hematology/Oncology Committee, University of Oklahoma Children’s Hospital
  2. 2022 - 2024
    Commiittee MemberOU Health Pharmacy & Therapeutics Committee, University of Oklahoma Children’s Hospital
  3. 2022 - present
    MemberPediatric Transplant and Cell Therapy
  4. 2022 - present
    Immune Reconstitution Study Committee MemberChildren's Oncology Group
  5. 2021 - present
    Reviewer/Board MemberInstitutional Review Board, Oklahoma Medical Research Foundation; Institutional Review Board
  6. 2018 - 2020
    Fellow RepresentativePediatric Bone Marrow Transplant Consortium, Children's Oncology Group
  7. 2018 - present
    MemberAmerican Society of Clinical Oncology
  8. 2017 - present
    MemberChildren's Oncology Group
  9. 2017 - present
    MemberAmerican Society for Transplantation and Cellular Therapy

Publications